Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowLeukemiaWhole-Body IrradiationBone Marrow CellsAnemia, AplasticTransplantation ConditioningGraft SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation, AutologousLeukemia, Myeloid, AcuteTransplantation ChimeraBusulfanTissue DonorsHematopoietic Stem Cell TransplantationLeukocyte TransfusionHistocompatibility TestingRecurrenceGraft vs Tumor EffectPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibilityRemission InductionRadiation ChimeraGraft vs Host ReactionCyclophosphamideGraft vs Leukemia EffectLymphocyte DepletionHematologic NeoplasmsAcute DiseaseTransplantation, IsogeneicBone and BonesLymphocyte TransfusionImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone Marrow PurgingMice, Inbred C57BLHematopoietic Stem CellsCombined Modality TherapyT-LymphocytesTreatment OutcomeChimeraImmunosuppressionTime FactorsLiver TransplantationMyelodysplastic SyndromesHematopoiesisNuclear FamilyTransplantation ImmunologyCyclosporineGraft RejectionSurvival AnalysisActuarial AnalysisRetrospective StudiesHLA AntigensCytomegalovirus InfectionsFatal OutcomeCytarabineHematologic DiseasesMice, Inbred BALB CLymphoma, Non-HodgkinKidney TransplantationSevere Combined ImmunodeficiencyLeukemia, LymphoidSurvival RateAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesBone Marrow DiseasesDisease-Free SurvivalSpleenLeukocyte CountPancytopeniaGranulocyte Colony-Stimulating FactorLeukemia, ExperimentalLymphomaAnemia, Refractory, with Excess of BlastsMethotrexateNeoplasm, ResidualStem Cell TransplantationInfectionLeukemia, Myelomonocytic, AcuteBone Marrow ExaminationEtoposideFlow CytometryPrognosisImmunophenotypingCyclosporinsLeukemia, Lymphocytic, Chronic, B-CellAntilymphocyte SerumMice, Inbred AKRMultiple MyelomaCytogeneticsPhiladelphia ChromosomeImmunocompromised HostGanciclovirColony-Forming Units AssayLife TablesHeart Transplantation